|
![]() |
|||
|
||||
OverviewIn this issue of Hematology/Oncology Clinics, guest editors Drs. Sophie Lanzkron and Jane Little bring their considerable expertise to the topic of Sickle Cell Syndromes. Top experts in the field cover key topics such as structural racism and impact on sickle cell disease (SCD); pathophysiology and biomarkers of SCD; genetic modifiers of SCD; allogeneic transplant and gene therapy: reproductive health; chronic pain; and more. Contains 16 relevant, practice-oriented topics including innovative therapies, addressing challenging complications, novel science on mechanisms of disease; preventing cognitive decline in people with SCD; quality of life in SCD; and more. Provides in-depth clinical reviews on sickle cell syndromes, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews. Full Product DetailsAuthor: Sophie Lanzkron, MD, MHS (Professor of Medicine) , Jane Little (Professor of Medicine, University of North Carolina at Chapel Hill)Publisher: Elsevier - Health Sciences Division Imprint: Elsevier - Health Sciences Division Volume: 36 Weight: 0.590kg ISBN: 9780323986632ISBN 10: 0323986633 Pages: 240 Publication Date: 18 November 2022 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsStructural Racism and Impact on Sickle Cell Disease: Sickle Cell Lives Matter Sickle Cell Disease Pathophysiology and Related Molecular and Biophysical Biomarkers Genetic Modifiers of Sickle Cell Disease Economics of Sickle Cell Disease and Evidence to Support Comprehensive Care Quality of Life in Sickle Cell Disease: What Matters Chronic Pain: Prevalence and Management The Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell Disease Clinical Vignettes Part I Clinical Vignettes Part II The Cardiopulmonary Complications of Sickle Cell Disease Sickle Cell Disease and the Kidney: Filters Gone Awry Go the Distance: Reproductive Health Care for People with Sickle Cell Disease Genotyping and the Future of Transfusion in Sickle Cell Disease The Evolving Landscape of Drug Therapies for Sickle Cell Disease Allogeneic Transplant and Gene Therapy: Evolving Toward a CureReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |